Results 221 to 230 of about 609,075 (334)

Comprehensive Single-Cell Characterization of LDL in the Ovarian Cancer Microenvironment and Its Prognostic Implications. [PDF]

Mediators Inflamm
Tian K, Liu J, Zhou L, Gao Y, Wei S, Jinhui L.   +5 more
europepmc   +1 more source

Targeting ATP citrate lyase to reduce LDL cholesterol [PDF]

, 2019
Karina Huynh
openalex   +1 more source

Left ventricular function improvement during angiotensin receptor–neprilysin inhibitor treatment in a cohort of HFrEF/HFmrEF patients

ESC Heart Failure, Volume 12, Issue 2, Page 1151-1165, April 2025.
Prediction of LVEF improvement in patients with HFrEF and HFmrEF following treatment with Sacubitril/Valsartan. Workflow of this study investigating the functional capacity improvement in response to Sacubitrail/Valsartsan in a real‐world scenario of heart failure treatment.
Florian Appenzeller, Tobias Harm, Manuel Sigle, Parwez Aidery, Klaus‐Peter Kreisselmeier, Livia Baas, Andreas Goldschmied, Meinrad Paul Gawaz, Karin Anne Lydia Müller   +8 more
wiley   +1 more source

Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors and Lipid Modulation in Heart Failure: A Narrative Review. [PDF]

Cureus
Neshat S, Moradi H, Bidares M, Heidari A, Falahati Marvast A, Ortega R, Heshmat K.   +6 more
europepmc   +1 more source

Left ventricular diastolic dysfunction worsens prognosis in patients with heart failure due to dilated cardiomyopathy

ESC Heart Failure, Volume 12, Issue 2, Page 1183-1193, April 2025.
Abstract Aims The prognostic significance of left ventricular (LV) diastolic dysfunction (LVDD) severity in patients with dilated cardiomyopathy (DCM) remains uncertain. This study aimed to evaluate the association of LVDD severity and elevated left atrial pressure (eLAP) with patient outcomes in stable, non‐acutely decompensated patients with DCM ...
Mateusz Winiarczyk, Ewa Dziewięcka, Sylwia Wiśniowska‐Śmiałek, Agnieszka Stępień, Katarzyna Graczyk, Agata Leśniak‐Sobelga, Marta Hlawaty, Jakub Woźniak, Maryia Savitskaya, Katarzyna Holcman, Magdalena Kostkiewicz, Piotr Podolec, Paweł Rubiś   +12 more
wiley   +1 more source

Progression of Established Atherosclerotic Lesions Is Not Inhibited by Endothelial Knockout of Caveolin-1-Brief Report. [PDF]

Arterioscler Thromb Vasc Biol
Muñiz-Anquela R, Redondo-Angulo I, Lewis EA, Lolo FN, González-Cintado L, Toledano-Donado M, Pulgarín-Alfaro M, Del Pozo MA, Bentzon JF.   +8 more
europepmc   +1 more source

LDL-Rezeptor [PDF]

, 2018
K. J. Lackner, D. Peetz
openaire   +1 more source

Antibodies against Oxidized LDL in Infants [PDF]

, 2001
A Steinerová, F Stožický, Jaroslav Ráček, Franz Tatzber, Tomáš Zima, Rudolf Šětina   +5 more
openalex   +1 more source

Dapagliflozin alleviates high‐fat‐induced obesity cardiomyopathy by inhibiting ferroptosis

ESC Heart Failure, Volume 12, Issue 2, Page 1358-1373, April 2025.
Abstract Aim: Dapagliflozin (Dapa) is a novel hypoglycaemic agent with multiple cardiovascular protective effects, and it is widely used in treatment of heart failure patients, but whether it can improve obese phenotype of heart failure and its mechanism is still unclear.
Di Chen, Jiahao Shi, Yue Wu, Lizhu Miao, Zilin Wang, Yixuan Wang, Siwei Xu, Yu Lou   +7 more
wiley   +1 more source

Impact of a Meds-to-Beds PCSK9i Initiation Program on LDL-C in Patients Undergoing ASCVD Revascularization

Daniel Lorenzatti, G Greenberg, Annalisa Filtz, Andrea Scotti, Vita Jaspan, Christine M. Park, Bethany Kalich, Laney K. Jones, Niranjan Kathe, Katherine E. Di Palo, Colette V. Browne, Evan C. Lipsitz, S. Forest, Azeem Latib, Mario J. García, Carlos J. Rodríguez, Michael D. Shapiro, Martha Gulati, Leandro Slipczuk   +18 more
openalex   +1 more source